Nov 30, 2005 by Brian GormanIs BioCryst For Real?Investors may have been right about BioCryst, but for the wrong reasons.
Nov 29, 2005 by Brian GormanWendy's Failed FruitAre patrons bored with healthy food, or is there a larger problem at the fast-food chain?
Nov 28, 2005 by Brian GormanBP's Low-Carbon DietBP's planned investment in alternative energy makes sense based on current trends.
Nov 23, 2005 by Brian GormanGM: China to the Rescue?Even GM's successful business in China could be at risk.
Nov 22, 2005 by Brian GormanSaying No to DrugsBritain's policy of restricting drug access should be on the radar screen of pharmaceutical investors.
Nov 21, 2005 by Brian GormanGM's Road BackIf the automaker truly wants to succeed, it has to do more than cut costs.
Nov 16, 2005 by Brian GormanBoeing Checks AirbusThe American company makes an effective move in the ongoing chess match with its European rival.
Nov 15, 2005 by Brian GormanMGP Conquers Carb CrashMGP Ingredients has suffered post-Atkins, but its other assets are helping it adjust.
Nov 14, 2005 by Brian GormanAOL Changes ChannelsAmerica Online and Warner Bros. will stream TV episodes online. Who's going to watch?
Nov 9, 2005 by Brian GormanCaremark's Room to GrowFickle investors may fret about near-term growth, but Caremark is prepared for the long haul.
Nov 8, 2005 by Brian GormanThe Tube or Yahoo!Yahoo!'s agreement with TiVo could be the beginning of a transformation.
Nov 7, 2005 by Brian GormanEgg on Starbucks' Face?Starbucks should avoid anything that equates it to McDonald's.
Nov 4, 2005 by Brian GormanCoal's Hot, Trinity DeliversThe diversified manufacturer is benefiting from the unique economic environment.
Nov 3, 2005 by Brian GormanDean Foods' Low-Fat StrategyThe company came through the hurricanes with solid results, thanks in part to a focus on costs.
Nov 2, 2005 by Brian GormanMedco's Bitter PillThe pharma benefits manager has hit a speed bump but looks well-positioned for the long haul.
Nov 1, 2005 by Brian GormanKendle's ResurgenceCan the contract researcher continue its growth without more acquisitions?
Oct 31, 2005 by Brian GormanCharles River Labs' SeesawThe company is balancing softness in its research models with strength in preclinical services.
Oct 28, 2005 by Brian GormanDough Keeps Rising at California PizzaThe pizza maker brought home another good quarter, and it seems to still have room to grow.
Oct 27, 2005 by Brian GormanBausch & Lomb's Cloudy QuarterAn accounting scandal at a subsidiary clouded third-quarter results, but the underlying business still looks good.
Oct 25, 2005 by Brian GormanAlbany Molecular's Mixed BagAlbany Molecular's new deal is overshadowed by a threat to a major revenue stream.
